These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1558110)

  • 21. The use of orbital radiotherapy for Graves' ophthalmopathy: quantitative review of the evidence.
    Wei RL; Cheng JW; Cai JP
    Ophthalmologica; 2008; 222(1):27-31. PubMed ID: 18097177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural history of graves' orbitopathy after treatment.
    Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M
    Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of radiation therapy in Graves' ophthalmopathy.
    Chowdhury AD; Moriarty MJ
    Australas Radiol; 1996 Nov; 40(4):422-3. PubMed ID: 8996904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypofractionated radiotherapy for Graves' orbitopathy.
    Heyd R; Strassmann G; Herkströter M; Martin T; Zamboglou N
    Rontgenpraxis; 2001; 54(3):94-100. PubMed ID: 11799870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exophthalmos in a young woman with no graves' disease - a case report of IgG4-related orbitopathy.
    Erdei A; Steiber Z; Molnar C; Berenyi E; Nagy EV
    BMC Ophthalmol; 2018 Jan; 18(1):5. PubMed ID: 29329570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified lateral orbital wall decompression in Graves' orbitopathy using computer-assisted planning.
    Spalthoff S; Jehn P; Zimmerer R; Rana M; Gellrich NC; Dittmann J
    Int J Oral Maxillofac Surg; 2018 Feb; 47(2):167-174. PubMed ID: 29096933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Course of proptosis in patients with Graves' disease after endoscopic orbital decompression.
    Ulualp SO; Massaro BM; Toohill RJ
    Laryngoscope; 1999 Aug; 109(8):1217-22. PubMed ID: 10443822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy?
    Ott M; Breiter N; Albrecht CF; Pradier O; Hess CF; Schmidberger H
    Br J Radiol; 2002 Jun; 75(894):514-7. PubMed ID: 12124238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radiotherapy of endocrine orbitopathy--state of the art].
    Prettenhofer U; Ramschak-Schwarzer S; Langmann A; Mayer R; Schedlbauer P; Hackl A
    Acta Med Austriaca; 2001; 28(4):97-8. PubMed ID: 11593899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follow-up of extended pterional orbital decompression in severe Graves' ophthalmopathy.
    Korinth MC; Ince A; Banghard W; Gilsbach JM
    Acta Neurochir (Wien); 2002 Feb; 144(2):113-20; discussion 120. PubMed ID: 11862510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiotherapy of severe ophthalmic Graves' disease.
    van Ouwerkerk BM; Wijngaarde R; Hennemann G; van Andel JG; Krenning EP
    J Endocrinol Invest; 1985 Jun; 8(3):241-7. PubMed ID: 3839805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orbital radiotherapy for thyroid-related orbitopathy.
    Behbehani R; Sergott RC; Savino PJ
    Curr Opin Ophthalmol; 2004 Dec; 15(6):479-82. PubMed ID: 15523191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of radiotherapy for Graves' ophthalmopathy.
    Konishi J; Iida Y; Kasagi K; Misaki T; Arai K; Endo K; Amemiya T; Abe M; Torizuka K
    Endocrinol Jpn; 1986 Oct; 33(5):637-44. PubMed ID: 3830071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfrontal orbital decompression after failure of transantral decompression in optic neuropathy of Graves' disease.
    Fatourechi V; Bartley GB; Garrity JA; Bergstralh EJ; Ebersold MJ; Gorman CA
    Mayo Clin Proc; 1993 Jun; 68(6):552-5. PubMed ID: 8497132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves' disease for evaluation of active inflammation.
    Uslu-Beşli L; Kabasakal L; Sağer S; Cicik E; Asa S; Sönmezoğlu K
    Nucl Med Commun; 2017 Nov; 38(11):964-970. PubMed ID: 28863123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiotherapy for Graves' ophthalmopathy: results at one year.
    Gorman CA
    Thyroid; 2002 Mar; 12(3):251-5. PubMed ID: 11952049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of ophthalmic Graves' disease.
    Leone CR
    Ophthalmology; 1984 Jul; 91(7):770-9. PubMed ID: 6548005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes of orbital irradiation combined with or without systemic high-dose or pulsed corticosteroids for Graves' ophthalmopathy.
    Tsujino K; Hirota S; Hagiwara M; Fukada S; Takada Y; Hishikawa Y; Kono M; Abe M
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):857-64. PubMed ID: 11020584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of exophthalmos using orbital ultrasonography and treatment of malignant exophthalmos with steroid therapy, orbital radiation therapy, and plasmapheresis.
    Yamamoto K; Saito K; Takai T; Yoshida S
    Prog Clin Biol Res; 1983; 116():189-205. PubMed ID: 6134291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute Graves orbitopathy.
    Kazim M; Trokel S; Moore S
    Ophthalmology; 1991 Sep; 98(9):1443-8. PubMed ID: 1945322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.